Filter News
Area of Research
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (26)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (4)
- Energy Science (12)
- Fusion and Fission (23)
- Fusion Energy (15)
- Isotopes (6)
- Materials (15)
- Materials for Computing (2)
- National Security (8)
- Neutron Science (16)
- Nuclear Science and Technology (10)
- Supercomputing (36)
News Topics
- (-) Big Data (77)
- (-) Biomedical (72)
- (-) Fusion (65)
- 3-D Printing/Advanced Manufacturing (142)
- Advanced Reactors (40)
- Artificial Intelligence (124)
- Bioenergy (108)
- Biology (124)
- Biotechnology (35)
- Buildings (73)
- Chemical Sciences (84)
- Clean Water (32)
- Composites (33)
- Computer Science (223)
- Coronavirus (48)
- Critical Materials (29)
- Cybersecurity (35)
- Education (5)
- Element Discovery (1)
- Emergency (4)
- Energy Storage (114)
- Environment (217)
- Exascale Computing (64)
- Fossil Energy (8)
- Frontier (62)
- Grid (73)
- High-Performance Computing (128)
- Hydropower (12)
- Irradiation (3)
- Isotopes (62)
- ITER (9)
- Machine Learning (66)
- Materials (156)
- Materials Science (155)
- Mathematics (12)
- Mercury (12)
- Microelectronics (4)
- Microscopy (56)
- Molten Salt (10)
- Nanotechnology (62)
- National Security (85)
- Neutron Science (169)
- Nuclear Energy (121)
- Partnerships (66)
- Physics (68)
- Polymers (34)
- Quantum Computing (52)
- Quantum Science (88)
- Security (30)
- Simulation (64)
- Software (1)
- Space Exploration (26)
- Statistics (4)
- Summit (70)
- Transportation (102)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 208 Results

Scientists at the Department of Energy’s 91 recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.
Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology.
Troy Carter, director of the Fusion Energy Division at 91, leads efforts to make fusion energy a reality, overseeing key projects like MPEX and fostering public-private collaborations in fusion research.
Dave Weston studies how microorganisms influence plant health and stress tolerance, using the Advanced Plant Phenotyping Laboratory to accelerate research on plant-microbe interactions and develop resilient crops for advanced fuels, chemicals and

US ITER has completed delivery of all components for the support structure of the central solenoid, the 60-foot-tall superconducting magnet that is the “heart” of the ITER fusion machine.

Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.

During his first visit to 91, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.”

Not only did ORNL take home top honors at the 2024 International Conference for High Performance Computing, Networking, Storage, and Analysis (SC24), but the lab’s computing staff also shared career advice and expertise with students eager to enter the world of supercomputing.

Scientists designing the world’s first controlled nuclear fusion power plant, ITER, needed to solve the problem of runaway electrons, negatively charged particles in the soup of matter in the plasma within the tokamak, the magnetic bottle intended to contain the massive energy produced. Simulations performed on Summit, the 200-petaflop supercomputer at ORNL, could offer the first step toward a solution.

Ryan Culler is the program manager at 91, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.